For marketing, product, and publishing managers in the pharmaceutical industry
- We create innovative online and offline print publishing solutions to ensure incremental reach
- Use our interactive and experimental products to develop a dialogue with healthcare professionals
We will help to shape a campaign that goes straight to your target
- With our experience in medical publishing, Elsevier can act as your strategic media partner in optimizing your reach and budget
- We can help you to frame your message in the most credible and relevant context
- Associate your advertising message with a well respected, peer reviewed publication
We can help you to maximize your contribution to a conference
- We have many years of experience in the publication of congress materials which are an ideal method for rapid and powerful dissemination of your conference material or scientific findings
- Increase brand awareness with onsite & pre-event conference exposure
- Support and engage conference participants
Journals & Platforms
We Publish over 450 Health Science Journals including some of the most influential in the field:
-
Pain
-
The Lancet
-
Journal of Hepatology
-
Gastroenterology
-
Healthcare Management Forum
-
International Journal of Infectious Diseases
-
The Lancet Infectious Diseases
-
Disability and Health Journal
-
The American Journal of Medicine
-
The Journal Of Hospital Infection
SciVerse- ScienceDirect
OncologyStat
Health Advance
TheLancet.com
Recent Clinical Trials
- Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Bhupendra Khatri, et al. The Lancet Neurology, Volume 10, Issue 6, June 2011, Pages 520-529.
- Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Klemens Budde et al. The Lancet Neurology, Volume 10, Issue 6, June 2011, Pages 520-529.
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. Javier Cortes, et al. The Lancet, Volume 377, Issue 9769, 12 March 2011-18 March 2011, Pages 914-923.
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.Luca Gianni, et al. The Lancet, Volume 377, Issue 9769, 12 March 2011-18 March 2011, Pages 914-923.
- Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial.Giuseppe Patti, et al. The American Journal of Cardiology, In Press, Corrected Proof, Available online 27 April 2011.
- Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.Diamant et al. The Lancet, Volume 375, Issue 9733, 26 June 2010-2 July 2010, Pages 2234-2243.
Conference Tools
We can help you organise and add value to your conference with the following tools and services:
MED Select
Content Direct
Abstracts on CD-Rom, USB or on the Web
CD-Rom Portal
Printing on Demand
Recent News
Forthcoming opportunities and events:
Steve Skinner
Read More
Opportunities at Simpar 2011 in Pavia
SIMPAR Group is pleased to announce the 4th SIMPAR Meeting which will be held on November 11-12th 2011 in the wonderful medieval setting of Pavia (Italy), as part of the celebrations for the 650 years from the foundation of Pavia’s University.
Read More
EyeforPharma: Europe’s largest pharma eMarketing summit
Europe’s largest pharma Marketing summit (6th annual, March 2nd- 3rd) has recently confirmed the highly acclaimed Dr Lucien Engelen Head of the Regional Acute Healthcare Network; Advisor to the Executive Board & Director REshape & Innovation Centre
Read More
12th Western Pacific Conference
The 12th Western Pacific Congress on Chemotherapy and Infectious Diseases is taking place in Singapore on 2nd - 5th December 2010. There are opportunities for sponsorship of the official abstracts in print and on CD or USB stick.
Read More
Sign up now for:
- Quarterly newsletter and product alerts
- Pharma marketing intelligence
- Free access to webinars and workshops
Conference Calendar
Find us at the following Conferences:
International AIDS Society Meeting
July 17 2011 Rome
Visit the Conference Website